The prevalence of cancer. Estimates based on the Connecticut Tumor Registry

The New England Journal of Medicine
A R FeldmanM D Naughton

Abstract

Cancer incidence and mortality do not fully reflect the effect of cancer. To estimate the number of persons alive who have a history of cancer, we derived prevalence rates based on data from the Connecticut Tumor Registry. We did not attempt to distinguish between people who had been cured of cancer and those who still had the disease. In 1982 the age-adjusted prevalence rates of cancer among males and females were 1,789 and 2,222, respectively, per 100,000. Age-specific prevalence rates were highest among the elderly; 12 percent of men and 11 percent of women over 70 had previously been given a diagnosis of cancer. Breast cancer in females and prostate cancer in males were the two most prevalent malignant diseases. We estimate that about 5 million persons alive in the United States today have at one time received a diagnosis of cancer.

References

Mar 1, 1978·Journal of the National Cancer Institute·S S Devesa, D T Silverman
Jun 1, 1985·Pediatric Clinics of North America·R Byrd
Jul 25, 1985·The New England Journal of Medicine·F Mullan
Aug 1, 1984·Journal of the National Cancer Institute·J L YoungE S Pollack
Dec 1, 1958·Journal of Chronic Diseases·S J CUTLER, F EDERER

❮ Previous
Next ❯

Citations

Jul 19, 2002·Cancer·Andrea MicheliLynn Ries
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Mar 29, 2002·Psycho-oncology·Joan R Bloom
Jan 1, 1990·The Prostate·H B Carter, D S Coffey
Jul 12, 2002·Statistics in Medicine·Norman PhillipsMary L McBride
Oct 31, 2002·Statistics in Medicine·Arduino VerdecchiaRiccardo Capocaccia
Oct 1, 1993·Journal of Behavioral Medicine·J B Rounds, M A Zevon
Oct 19, 2006·World Journal of Urology·Dragan J GolijaninSeth P Lerner
Jun 1, 2005·The Medical Clinics of North America·Toni P Miles
Jun 25, 1998·European Journal of Radiology·W C Black
Feb 26, 1998·American Journal of Preventive Medicine·R L FerriniL Hill
Mar 25, 2000·Endocrinology and Metabolism Clinics of North America·B Burguera, H Gharib
Oct 3, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Gauri Patel, Y K Agrawal
Jul 18, 1991·The New England Journal of Medicine·H K Koh
Apr 29, 1993·The New England Journal of Medicine·W C Black, H G Welch
Jun 24, 1993·The New England Journal of Medicine·M M FarleyD S Stephens
Feb 6, 2007·Thyroid : Official Journal of the American Thyroid Association·Toshihisa OgawaMichio Kaminishi
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MicheliUNKNOWN EUROPREVAL Working Group
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R CapocacciaUNKNOWN EUROPREVAL Working Group
Sep 2, 1999·Journal of the National Cancer Institute·M HewittS Devesa
Mar 2, 2006·Journal of the National Cancer Institute·George N NaumovNava Almog
Nov 15, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A M Benhamiche-BouvierJ Faivre
Feb 13, 2001·Journal of Epidemiology and Community Health·R M Merrill
Aug 5, 2011·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Rishi Nayyar, Narmada P Gupta
Jul 22, 1995·Lancet·J J Goedert, T R Coté
Feb 26, 2003·Radiology·Stephen J SwensenMedy A Clemens
Sep 1, 1996·Cancer Causes & Control : CCC·R M Merrill, E J Feuer
Jul 1, 1990·Cancer Causes & Control : CCC·R CapocacciaF Berrino
Nov 1, 1988·American Journal of Public Health·D I Gregorio, J V Linden
Aug 29, 2007·Statistics in Medicine·Arianna SimonettiAngela Mariotto
Jun 1, 1987·Baillière's Clinical Haematology·M A Baker
Aug 29, 2006·European Urology·Susanne FuesselManfred P Wirth
May 23, 1998·British Journal of Urology·B H MarajA F Markham
Oct 20, 2001·AJR. American Journal of Roentgenology·R J Stanley
Sep 20, 2002·AJR. American Journal of Roentgenology·Cheryl R HermanLaurie L Fajardo
Sep 20, 2002·AJR. American Journal of Roentgenology·Stephen J Swensen
Sep 15, 1992·Statistics in Medicine·A J ColdmanT Braun
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward M MessingJason Gee
Jan 1, 1991·Preventive Medicine·L G KesslerM L Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.